Do studies in caveolin-knockouts teach us about physiology and pharmacology or instead, the ways mice compensate for 'lost proteins'?

British Journal of Pharmacology

Volumn 150, Issue 3, 2007, Pages 251-254

  Insel, P A ^a,b   Patel, H H ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c University of California   (United States)

Author keywords

adrenoceptors; Caveolae; G protein receptors; Lipid rafts; Nitric oxide synthase; Vasoreactivity

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BETA 1 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BETA CATENIN; CAVEOLIN 1; CAVEOLIN 2; CAVEOLIN 3; CYCLIN D1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; G PROTEIN COUPLED RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE SYNTHASE; VASCULOTROPIN; WNT PROTEIN;

ARTERY DIAMETER; ARTERY WALL; CAVEOLA; CELL FRACTIONATION; CELL PROLIFERATION; ELECTRON MICROSCOPY; ENZYME ACTIVATION; ENZYME ACTIVITY; FLUORESCENCE RESONANCE ENERGY TRANSFER; IMMUNOBLOTTING; IMMUNOPRECIPITATION; KNOCKOUT MOUSE; LIFESPAN; LIPID METABOLISM; LIPID RAFT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN TRANSPORT; REVIEW; VASCULARIZATION; VASODILATATION;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CAVEOLIN 1; FEMALE; MALE; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; PHARMACOLOGY; PHENOTYPE; PHYSIOLOGY; REPRODUCIBILITY OF RESULTS;

EID: 33846852186     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706981     Document Type: Review

References (31)

1. Balijepalli RC, Foell JD, Hall DD, Hell JW, Kamp TJ (2006). Localization of cardiac L-type ca(2+) channels to a caveolar macromolecular signaling complex is required for beta(2)-adrenergic regulation. Proc Natl Acad Sci USA 103: 7500-7505.
2. Bergdahl A, Sward K (2004). Caveolae-associated signaling in smooth muscle. Can J Physiol Pharmacol 82: 289-299.
3. Bouras T, Lisanti MP, Pestell RG (2004). Caveolin-1 in breast cancer. Cancer Biol Ther 3: 931-941.
4. Cheng X, Jaggar JH (2006). Genetic ablation of caveolin-1 modifies Ca2+ spark coupling in murine arterial smooth muscle cells. Am J Physiol Heart Circ Physiol 290: H2309-H2319.
5. Cohen AW, Hnasko R, Schubert W, Lisanti MP (2004). Role of caveolae and caveolins in health and disease. Physiol Rev 84: 1341-1379.
6. Cohen AW, Razani B, Wang XB, Combs TP, Williams TM, Scherer PE et al. (2003). Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. Am J Physiol Cell Physiol 285: C222-C235.
7. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B et al. (2001). Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293: 2449-2452.
8. Drake MT, Shinoy SK, Lefkowitz RJ (2006). Trafficking of G protein-coupled receptors. Circ Res 99: 570-582.
9. El-Yazbi AF, Cho WJ, Boddy G, Schulz R, Daniel EE (2006). Impact of caveolin-1 knockout on NANC relaxation in circular muscles of the mouse small intestine compared with longitudinal muscles. Am J Physiol Gastrointest Liver Physiol 290: G394-G403.
10. Fernandez MA, Albor C, Ingelmo-Torres M, Nixon SJ, Ferguson C, Kurzchalia T et al. (2006). Caveolin-1 is essential for liver regeneration. Science 313: 1628-1632.
11. Gonzalez E, Nagiel A, Lin AG, Nolan DE, Michel T (2004). Small interfering RNA-mediated down-regulation of caveolin-1 differentially modulates signaling pathways in endothelial cells. J Biol Chem 279: 40659-40669.
12. Gratton JP, Bernatchez P, Sessa WC (2004). Caveolae and caveolins in the cardiovascular system. Circ Res 94: 1408-1417.
13. Hassan GS, Jasmin JF, Schubert W, Frank PG, Lisanti MP (2004). Caveolin-1 deficiency stimulates neointima formation during vascular injury. Biochemistry 43: 8312-8321.
14. Hnasko R, Lisanti MP (2003). The biology of caveolae: lessons from caveolin knockout mice and implications for human disease. Mol Intervent 3: 445-464.
15. Insel PA, Head BP, Patel HH, Roth DM, Bundey RA, Swaney JS (2005). Compartmentation of G-protein-coupled receptors and their signaling components in lipid rafts and caveolae. Biochem Soc Trans 33 (Part 5): 1131-1134.
16. Le Lay S, Kurzchalia TV (2005). Getting rid of caveolins: phenotypes of caveolin-deficient animals. Biochim Biophys Acta 1746: 322-333.
17. Li J, Hassan GS, Williams TM, Minetti C, Pestell RG, Tanowitz HB et al. (2005a). Loss of caveolin-1 causes the hyper-proliferation of intestinal crypt stem cells, with increased sensitivity to whole body gamma-radiation. Cell Cycle 4: 1817-1825.
18. Li XA, Everson WV, Smart EJ (2005b). Caveolae, lipid rafts, and vascular disease. Trends Cardiovasc Med 15: 92-96.
19. Luksha L, Poston L, Gustafsson JA, Aghajanova L, Kublickiene K (2005). Gender-specific alteration of adrenergic responses in small femoral arteries from estrogen receptor-beta knockout mice. Hypertension 46: 1163-1168.
20. Medina FA, Williams TM, Sotgia F, Tanowitz HB, Lisanti MP (2007). A novel role for caveolin-1 in B lymphocyte function and the development of thymus-independent immune responses. Cell Cycle 5: 1865-1871.
21. Neidhold S, Eichhorn B, Kasper M, Ravens U, Kaumann AJ (2007). The function of α- and β-adrenoceptors of the saphenous artery in caveolin-1 knockout and wild-type mice. Br J Pharmacol 150: 261-270 (this issue).
22. Ostrom RS, Insel PA (2004). The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology. Br J Pharmacol 43: 235-245.
23. Park DS, Cohen AW, Frank PG, Razani B, Lee H, Williams TM et al. (2003). Caveolin-1 null (-/-) mice show dramatic reductions in life span. Biochemistry 42: 15124-15131.
24. Pike LJ (2005). Growth factor receptors, lipid rafts and caveolae: an evolving story. Biochim Biophys Acta 1746: 260-273.
25. Rapacciuolo A, Suvarna S, Barki-Harrington L, Luttrell LM, Cong M, Lefkowitz RJ et al. (2003). Protein kinase A and G protein-coupled receptor kinase phosphorylation mediates beta-1 adrenergic receptor endocytosis through different pathways. J Biol Chem 278: 35403-35411.
26. Shenoy SK, Lefkowitz RJ (2005). Seven-transmembrane receptor signaling through beta-arrestin. Sci STKE 308: cm10.
27. Sonveaux P, Martinive P, DeWever J, Batova Z, Daneau G, Pelat M et al. (2004). Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis. Circ Res 95: 154-161.
28. Swaney JS, Patel HH, Yokoyama U, Head BP, Roth DM, Insel PA (2006). Focal adhesions in (myo)fibroblasts scaffold adenylyl cyclase with phosphorylated caveolin. J Biol Chem 281: 17173-17179.
29. Trushina E, Du Charme J, Parisi J, McMurray CT (2006). Neurological abnormalities in caveolin-1 knock out mice. Behav Brain Res 172: 24-32.
30. Yu J, Bergaya S, Murata T, Alp IF, Bauer MP, Lin MI et al. (2006). Direct evidence for the role of caveolin-1 and caveolae in mechano-transduction and remodeling of blood vessels. J Clin Invest 116: 1284-1291.
31. Zuo L, Ushio-Fukai M, Ikeda S, Hilenski L, Patrushev N, Alexander RW (2005). Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: role in redox signaling and vascular hypertrophy. Arterioscler Thromb Vasc Biol 25: 1824-1830.